LITERATURE

Mammogram

Errors in Mammography Cannot be Solved Through Technology Alone
Ekpo EU, Alakhras M, Brennan P. Errors in Mammography Cannot be Solved Through Technology Alone. Asian Pac J Cancer Prev. 2018;19(2):291-301. Published 2018 Feb 26. doi:10.22034/APJCP.2018.19.2.291
https://pubmed.ncbi.nlm.nih.gov/29479948/

Why do women refrain from mammography screening?
Sterlingova T, Lundén M. Why do women refrain from mammography screening?. Radiography (Lond). 2018;24(1):e19-e24. doi:10.1016/j.radi.2017.07.006
https://pubmed.ncbi.nlm.nih.gov/29306388/

Benefits and harms of mammography screening
Løberg, M., Lousdal, M.L., Bretthauer, M. et al. Benefits and harms of mammography screening. Breast Cancer Res 17, 63 (2015).
https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-015-0525-z

The Future of Contrast-Enhanced Mammography
Matthew F. Covington, Victor J. Pizzitola, Roxanne Lorans, Barbara A. Pockaj, Donald W. Northfelt, Catherine M. Appleton, and Bhavika K. Patel. The Future of Contrast-Enhanced Mammography. American Journal of Roentgenology 2018 210:2, 292-300 
https://www.ajronline.org/doi/full/10.2214/AJR.17.18749

Tomo

Screening Mammography and Digital Breast Tomosynthesis
Funaro K, Drukteinis J, Falcon S. Screening Mammography and Digital Breast Tomosynthesis: Controversies. South Med J. 2017;110(10):607-613. doi:10.14423/SMJ.000000000000070
https://pubmed.ncbi.nlm.nih.gov/28973699/

Artificial Intelligence for Mammography and Digital Breast Tomosynthesis: Current Concepts and Future Perspectives
Geras KJ, Mann RM, Moy L. Artificial Intelligence for Mammography and Digital Breast Tomosynthesis: Current Concepts and Future Perspectives. Radiology. 2019;293(2):246-259. doi:10.1148/radiol.2019182627
https://pubmed.ncbi.nlm.nih.gov/31549948/

The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme–a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone
Gilbert FJ, Tucker L, Gillan MG, et al. The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme–a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone. Health Technol Assess. 2015;19(4):i-136. doi:10.3310/hta19040
https://pubmed.ncbi.nlm.nih.gov/25599513/

Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density.
Conant EF, Barlow WE, Herschorn SD, et al. Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density. JAMA Oncol. 2019;5(5):635–642. doi:10.1001/jamaoncol.2018.7078
https://jamanetwork.com/journals/jamaoncology/fullarticle/2726028

Digital breast tomosynthesis plus synthesised images versus standard full-field digital mammography in population-based screening (TOSYMA): protocol of a randomised controlled trial.
Weigel S, Gerss J, Hense HW, et al. Digital breast tomosynthesis plus synthesised images versus standard full-field digital mammography in population-based screening (TOSYMA): protocol of a randomised controlled trial. BMJ Open. 2018;8(5):e020475. Published 2018 May 14. doi:10.1136/bmjopen-2017-020475
https://bmjopen.bmj.com/content/bmjopen/8/5/e020475.full.pdf  

TOSYMA Trial Website
https://www.referenzzentrum-ms.de/aktuelles/tosyma-study-examines-influence-of-tomosynthesis-in-breast-cancer-screening/

Tmist Trial Webpage
https://www.cancer.gov/about-cancer/treatment/clinical-trials/nci-supported/tmist#trial
https://ecog-acrin.org/tmist

Screening

Breast cancer screening in young women
Desreux JAC. Breast cancer screening in young women. Eur J Obstet Gynecol Reprod Biol. 2018;230:208-211. doi:10.1016/j.ejogrb.2018.05.018
https://www.ejog.org/article/S0301-2115(18)30233-1/fulltext

The Role of Ultrasound in Breast Cancer Screening: The Case for and Against Ultrasound
Geisel J, Raghu M, Hooley R. The Role of Ultrasound in Breast Cancer Screening: The Case for and Against Ultrasound. Semin Ultrasound CT MR. 2018;39(1):25-34. doi:10.1053/j.sult.2017.09.006
https://www.sciencedirect.com/science/article/abs/pii/S0887217117301014?via%3Dihub

Breast cancer screening error: fatal mistake or lucky escape?
Hawkes N. Breast cancer screening error: fatal mistake or lucky escape?. BMJ. 2018;361:k2036. Published 2018 May 8. doi:10.1136/bmj.k2036
https://www.bmj.com/content/361/bmj.k2036

Supplemental MRI Screening for Women with Extremely Dense Breast Tissue
Bakker MF, de Lange SV, Pijnappel RM, et al. Supplemental MRI Screening for Women with Extremely Dense Breast Tissue. N Engl J Med. 2019;381(22):2091-2102. doi:10.1056/NEJMoa1903986
https://pubmed.ncbi.nlm.nih.gov/31774954/

Screening for breast cancer in 2018-what should we be doing today?
Seely JM, Alhassan T. Screening for breast cancer in 2018-what should we be doing today?. Curr Oncol. 2018;25(Suppl 1):S115-S124. doi:10.3747/co.25.3770
https://pubmed.ncbi.nlm.nih.gov/29910654/

International evaluation of an AI system for breast cancer screening
McKinney SM, Sieniek M, Godbole V, et al. International evaluation of an AI system for breast cancer screening. Nature. 2020;577(7788):89-94. doi:10.1038/s41586-019-1799-6
https://www.nature.com/articles/s41586-019-1799-6 /

Breast Cancer

Statin drugs to reduce breast cancer recurrence and mortality
Beckwitt CH, Brufsky A, Oltvai ZN, Wells A. Statin drugs to reduce breast cancer recurrence and mortality. Breast Cancer Res. 2018;20(1):144. Published 2018 Nov 20. doi:10.1186/s13058-018-1066-z
https://pubmed.ncbi.nlm.nih.gov/30458856/

Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression
Ren J, Smid M, Iaria J, et al. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression. Breast Cancer Res. 2019;21(1):109. Published 2019 Sep 18. doi:10.1186/s13058-019-1194-0
https://pubmed.ncbi.nlm.nih.gov/31533776/

Characterization of organoid cultured human breast cancer
Goldhammer N, Kim J, Timmermans-Wielenga V, Petersen OW. Characterization of organoid cultured human breast cancer. Breast Cancer Res. 2019;21(1):141. Published 2019 Dec 11. doi:10.1186/s13058-019-1233-x
https://pubmed.ncbi.nlm.nih.gov/31829259/